“DESIGN AND IN VIVO EVALUATION OF CONTROLLED RELEASE GLICLAZIDE TRILAYER MATRIX TABLETS IN THE MANAGEMENT OF DIABETES MELLITUS”, Int. J. Pharm. Sci. Drug Res., vol. 10, no. 5, pp. 410–417, Sep. 2018, doi: 10.25004/IJPSDR.2018.100508.